Atrandi Biosciences

Series-A
atrandi.com Biotech & Healthcare Vilnius, Lithuania
Total Funding $25M
Latest Round $25M Series-A
Last Announced Feb 18, 2025
Investors 6 Backers
Decision Makers 4 Verified

About Atrandi Biosciences

Advanced single-cell solutions by Atrandi. Discover high-throughput single-cell technologies for genomics, screening, and biological innovation.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Vilnius, Lithuania
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website atrandi.com
Domain Registered Date Dec 30, 2022

Social & Network Presence

X / Twitter Profile @AtrandiBio (56 followers) Created on May 2024
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $25,000,000 · Series-A

    fundraisingfox.com

  2. Milestone

    X account created (@AtrandiBio)

    56 followers

  3. Milestone

    Website domain registered

    atrandi.com

Investors & Backers

6
GRIDS Capital
Lux Capital
Metaplanet Holdings
Microsoft
Practica Capital
Vsquared Ventures

Funding History

1 Round
Series-A · Feb 18, 2025

Founders & Leadership

6

Dalius Kuciauskas

Founder

Work email & phone locked Unlock →

Juozas Nainys

Co-Founder & Chief Executive Officer

Work email & phone locked Unlock →

Karolis Leonavičius

Co-Founder & Chief Technology Officer

Work email & phone locked Unlock →

Linas Mažutis

Co-Founder & Scientific Advisor

Work email & phone locked Unlock →

Rapolas Žilionis

Co-Founder & Chief Scientific Officer

Work email & phone locked Unlock →

Sam Ropp

Chief Commercial Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts